Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Capri Holdings Ltd (CPRI) vs Illumina, Inc. (ILMN) Price & Performance

Capri Holdings LtdTrade
Illumina, Inc.Trade

Price performance (Past 24H)

Key statistics

Capri Holdings Ltd vs Illumina, Inc. — how do they compare? Capri Holdings Ltd trades at $15.15 (market cap $1.75B), while Illumina, Inc. trades at $190.32 (market cap $29.12B). The key difference: Illumina, Inc. is far larger — about 16.6× Capri Holdings Ltd's market cap, and Illumina, Inc. is trading nearer its 52-week high, Capri Holdings Ltd nearer its low. Which is the better fit depends on your goals.

CPRIILMN
Market Cap
$1.75B$29.12B
Sector
Consumer StaplesHealth
52-Week High
$27.66$205.10
52-Week Low
$14.98$91.00
Enterprise Value
$3.03B$30.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Capri Holdings Ltd

CPRI trades at $15.43, down 65% over five years but showing recent earnings momentum with three consecutive quarterly beats. The stock faces bearish technical signals with moving averages indicating downward pressure, while fundamentals reveal declining revenue from $5.7B in 2022 to $4.4B in 2025 and a significant net loss of -$1.18B. Analyst consensus sits at $19.60 with mixed ratings (44% Buy, 52% Hold), reflecting cautious optimism about the company's turnaround strategy post-Versace sale.

The investment case hinges on CPRI's ability to stabilize Michael Kors and grow Jimmy Choo profitability, but risks include ongoing revenue declines, luxury market softness, and high debt levels. With the current price near 52-week lows and 27% upside to consensus target, the stock offers potential for recovery if management executes its revamp plans successfully, though macroeconomic headwinds and brand challenges remain significant concerns.

Illumina, Inc.

Illumina (ILMN) trades at $191.79, up 2.04% today, with a neutral technical signal and strong fundamental recovery. The stock shows bullish moving averages but faces resistance near $194. Recent earnings beats and a return to profitability in 2025, with $850M net income, highlight operational turnaround. Revenue remains stable around $4.3B, supported by robust gross margins of 66.38%.

Outlook is positive with analyst consensus Buy rating and $201.58 price target, though high P/E of 35.98 poses valuation risk. Key opportunities include sequencing demand and AI partnerships, while risks involve debt levels and competitive pressures. Institutional activity is mixed, with some funds increasing stakes amid earnings momentum.

Returns comparison

Trailing returns across standard periods

About Capri Holdings Ltd

Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 800 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.

Read more on CPRI

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN